Lanzamiento Enero 2027

Ensayo controlado aleatorizado2009Financiación no declarada

Effects of extra virgin olive oil supplementation at two different low doses on lipid profile in mild hypercholesterolemic subjects: a randomised clinical trial

Violante B, Gerbaudo L, Borretta G, Tassone F

Journal of endocrinological investigation · 18 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2009-03-24 · J Endocrinol Invest · vol. 32 · número 10 · págs. 794–796
Editorial
Springer Science+Business Media
Citado
25 citas · más que el 71% de estudios similares · 1.0× el promedio de su campo
Referencias
16 trabajos
Acceso
De pago
Áreas de investigación
Edible Oils Quality and Analysis · Fatty Acid Research and Health · Lipoproteins and Cardiovascular Health
Palabras clave
extra virgin olive oil, olive oil supplementation, hypercholesterolemia, lipid profile, apolipoprotein B, apolipoprotein A-I, atherogenic index of plasma, LDL cholesterol, HDL cholesterol, triglycerides, dose-response relationship, Mediterranean diet, cardiovascular risk factors
MeSH
humans, hypercholesterolemia, lipids, plant oils, statistics, nonparametric, prospective studies, diet, mediterranean, blood pressure, dose-response relationship, drug, dietary supplements, adult, aged, middle aged, female, male, olive oil, surveys and questionnaires

4 autores

  • Benedetto Violante🇮🇹Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo
  • L. Gerbaudo🇮🇹Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo
  • Giorgio Borretta🇮🇹Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo
  • Francesco Tassone🇮🇹 · autor de correspondenciaAzienda Sanitaria Ospedaliera S.Croce e Carle Cuneo

Resumen

El texto original del estudio, en el idioma en que se publicó.

Olive oil, the principal fat of Mediterranean Diet, is known to improve several cardiovascular risk factors at relatively high doses together with intensive modifications of dietary habits. Since this is hard to obtain in the long term, an intervention with encapsulated oil supplements might be more feasible. Aim of this preliminary study was to investigate the effects of the supplementation of a moderate amount of encapsulated extra virgin olive oil vs a lower dose in mildly hypercholesterolemic subjects, as part of their established diet, on blood lipid profile. A prospective randomized study was performed. Thirty-four mildly hypercholesterolemic subjects [age, mean+/-SD: 46+/-7 yr; total cholesterol (TC): 235+/-28 mg/dl] were randomly assigned to receive 2 g (group A) or 4 g (group B) per os of extra-virgin olive oil for 3 months. TC, triglycerides (TG), LDL cholesterol, HDL cholesterol, apolipoprotein A1 (Apo-AI), apolipoprotein B (Apo-B), and atherogenic index of plasma (AIP) were evaluated at the beginning and at the end of the study. In group B, but not in group A, a significant reduction of Apo-B values (7%) was observed; TG concentrations showed a trend towards reduction and Apo-A1 values a trend towards increase (9%). A significant decrease in Apo-B/Apo-A1 ratio (p<0.01) was also observed in group B. Extra virgin olive oil supplementation significantly decreased AIP from baseline in group B (p<0.05). The results of the present study seem to suggest that the daily supplementation, on top of the normal diet, of at least 4 g of extra virgin olive oil, in mildly hypercholesterolemic subjects, is associated to favorable modifications of the plasmatic lipid profile.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.